PMC:7075884 / 5524-5911 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"232","span":{"begin":40,"end":43},"obj":"Gene"},{"id":"233","span":{"begin":33,"end":36},"obj":"Gene"},{"id":"234","span":{"begin":26,"end":29},"obj":"Gene"},{"id":"235","span":{"begin":55,"end":59},"obj":"Species"},{"id":"236","span":{"begin":265,"end":269},"obj":"Species"},{"id":"241","span":{"begin":9,"end":24},"obj":"Chemical"},{"id":"242","span":{"begin":280,"end":284},"obj":"Chemical"},{"id":"243","span":{"begin":384,"end":386},"obj":"Chemical"},{"id":"248","span":{"begin":203,"end":211},"obj":"Disease"},{"id":"254","span":{"begin":136,"end":150},"obj":"CellLine"},{"id":"255","span":{"begin":164,"end":167},"obj":"CellLine"}],"attributes":[{"id":"A232","pred":"tao:has_database_id","subj":"232","obj":"Gene:54360"},{"id":"A233","pred":"tao:has_database_id","subj":"233","obj":"Gene:51316"},{"id":"A234","pred":"tao:has_database_id","subj":"234","obj":"Gene:3229"},{"id":"A235","pred":"tao:has_database_id","subj":"235","obj":"Tax:10359"},{"id":"A236","pred":"tao:has_database_id","subj":"236","obj":"Tax:10359"},{"id":"A241","pred":"tao:has_database_id","subj":"241","obj":"MESH:C112485"},{"id":"A242","pred":"tao:has_database_id","subj":"242","obj":"MESH:C118647"},{"id":"A243","pred":"tao:has_database_id","subj":"243","obj":"MESH:C112485"},{"id":"A248","pred":"tao:has_database_id","subj":"248","obj":"MESH:D007239"},{"id":"A254","pred":"tao:has_database_id","subj":"254","obj":"CVCL:3285"},{"id":"A255","pred":"tao:has_database_id","subj":"255","obj":"CVCL:3285"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Figure 1 Ginkgolic Acids (C13:0, C15:1, C17:1) inhibit HCMV in a dose-dependent manner and prevents plaque formation. (A) Monolayers of human foreskin fibroblasts (HFF) were inoculated with 50–100 cells infected with one of two cell-associated clinical isolates of HCMV (CH19 and BI-6) in a total of 4 wells per drug concentration followed by treatment with medium containing 0–10 µM GA."}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T27","span":{"begin":142,"end":150},"obj":"Body_part"},{"id":"T28","span":{"begin":151,"end":162},"obj":"Body_part"},{"id":"T29","span":{"begin":197,"end":202},"obj":"Body_part"},{"id":"T30","span":{"begin":228,"end":232},"obj":"Body_part"}],"attributes":[{"id":"A27","pred":"fma_id","subj":"T27","obj":"http://purl.org/sig/ont/fma/fma19639"},{"id":"A28","pred":"fma_id","subj":"T28","obj":"http://purl.org/sig/ont/fma/fma63877"},{"id":"A29","pred":"fma_id","subj":"T29","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A30","pred":"fma_id","subj":"T30","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"Figure 1 Ginkgolic Acids (C13:0, C15:1, C17:1) inhibit HCMV in a dose-dependent manner and prevents plaque formation. (A) Monolayers of human foreskin fibroblasts (HFF) were inoculated with 50–100 cells infected with one of two cell-associated clinical isolates of HCMV (CH19 and BI-6) in a total of 4 wells per drug concentration followed by treatment with medium containing 0–10 µM GA."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T65","span":{"begin":40,"end":45},"obj":"http://purl.obolibrary.org/obo/CLO_0002099"},{"id":"T66","span":{"begin":63,"end":64},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T67","span":{"begin":119,"end":120},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T68","span":{"begin":136,"end":141},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"},{"id":"T69","span":{"begin":142,"end":162},"obj":"http://purl.obolibrary.org/obo/CL_1001608"},{"id":"T70","span":{"begin":164,"end":167},"obj":"http://purl.obolibrary.org/obo/CLO_0052986"},{"id":"T71","span":{"begin":197,"end":202},"obj":"http://purl.obolibrary.org/obo/GO_0005623"},{"id":"T72","span":{"begin":228,"end":232},"obj":"http://purl.obolibrary.org/obo/GO_0005623"},{"id":"T73","span":{"begin":289,"end":290},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"Figure 1 Ginkgolic Acids (C13:0, C15:1, C17:1) inhibit HCMV in a dose-dependent manner and prevents plaque formation. (A) Monolayers of human foreskin fibroblasts (HFF) were inoculated with 50–100 cells infected with one of two cell-associated clinical isolates of HCMV (CH19 and BI-6) in a total of 4 wells per drug concentration followed by treatment with medium containing 0–10 µM GA."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T126","span":{"begin":26,"end":31},"obj":"Chemical"},{"id":"T127","span":{"begin":33,"end":38},"obj":"Chemical"},{"id":"T128","span":{"begin":33,"end":36},"obj":"Chemical"},{"id":"T129","span":{"begin":40,"end":45},"obj":"Chemical"},{"id":"T130","span":{"begin":312,"end":316},"obj":"Chemical"},{"id":"T131","span":{"begin":384,"end":386},"obj":"Chemical"}],"attributes":[{"id":"A126","pred":"chebi_id","subj":"T126","obj":"http://purl.obolibrary.org/obo/CHEBI_45919"},{"id":"A127","pred":"chebi_id","subj":"T127","obj":"http://purl.obolibrary.org/obo/CHEBI_75088"},{"id":"A128","pred":"chebi_id","subj":"T128","obj":"http://purl.obolibrary.org/obo/CHEBI_42504"},{"id":"A129","pred":"chebi_id","subj":"T129","obj":"http://purl.obolibrary.org/obo/CHEBI_36001"},{"id":"A130","pred":"chebi_id","subj":"T130","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"},{"id":"A131","pred":"chebi_id","subj":"T131","obj":"http://purl.obolibrary.org/obo/CHEBI_5206"},{"id":"A132","pred":"chebi_id","subj":"T131","obj":"http://purl.obolibrary.org/obo/CHEBI_73855"},{"id":"A133","pred":"chebi_id","subj":"T131","obj":"http://purl.obolibrary.org/obo/CHEBI_5354"}],"text":"Figure 1 Ginkgolic Acids (C13:0, C15:1, C17:1) inhibit HCMV in a dose-dependent manner and prevents plaque formation. (A) Monolayers of human foreskin fibroblasts (HFF) were inoculated with 50–100 cells infected with one of two cell-associated clinical isolates of HCMV (CH19 and BI-6) in a total of 4 wells per drug concentration followed by treatment with medium containing 0–10 µM GA."}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T22","span":{"begin":107,"end":116},"obj":"http://purl.obolibrary.org/obo/GO_0009058"}],"text":"Figure 1 Ginkgolic Acids (C13:0, C15:1, C17:1) inhibit HCMV in a dose-dependent manner and prevents plaque formation. (A) Monolayers of human foreskin fibroblasts (HFF) were inoculated with 50–100 cells infected with one of two cell-associated clinical isolates of HCMV (CH19 and BI-6) in a total of 4 wells per drug concentration followed by treatment with medium containing 0–10 µM GA."}

{"project":"LitCovid-sentences","denotations":[{"id":"T40","span":{"begin":0,"end":387},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Figure 1 Ginkgolic Acids (C13:0, C15:1, C17:1) inhibit HCMV in a dose-dependent manner and prevents plaque formation. (A) Monolayers of human foreskin fibroblasts (HFF) were inoculated with 50–100 cells infected with one of two cell-associated clinical isolates of HCMV (CH19 and BI-6) in a total of 4 wells per drug concentration followed by treatment with medium containing 0–10 µM GA."}